secwatch.observer — SEC 8-K summary
======================================

Issuer:     Beyond Air, Inc. (XAIR)
CIK:        0001641631
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001493152-25-006892
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Beyond Air Q3 FY2025 revenue $1.1M (+34% QoQ); cash burn $7.6M; CE Mark for LungFit PH in Europe
--------------------------------------------------------------------------------

- Revenue $1.1M for Dec 31, 2024 quarter, up 34% from $0.8M in prior quarter and up from $0.4M YoY.
- Cash, cash equivalents and marketable securities $10.9M; debt $11.8M; cash burn $7.6M in quarter.
- Received CE Mark for LungFit PH in Europe; market authorization in Australia; initial shipments expected later 2025.
- Six new U.S. hospital starts for LungFit PH in Q3; CE Mark triggers $1M milestone from Getz Healthcare due in Q4 FY2025.
- NeuroNOS appointed Nobel laureate Prof. Roger D. Kornberg to Scientific Advisory Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641631/000149315225006892/0001493152-25-006892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641631/000149315225006892/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer